Perrigo to Present at the Canaccord 46th Annual Growth Conference

Rhea-AI Summary

Perrigo (NYSE: PRGO) announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra will present at the Canaccord 46th Annual Growth Conference on Wednesday, August 12 at 10:30 AM EDT. The presentation will be webcast via the Perrigo investor relations website.

Perrigo describes itself as a leading pure-play self-care company focused on over-the-counter health and wellness products in North America and Europe, leveraging cash-generative store-brand private label offerings to invest in branded products such as Opill, Mederma, Compeed, EllaOne, and Jungle Formula.

Market Context

PRGO's prior presentation announcement was followed by a -3.74% 24-hour reaction, providing context ...

Analysis

PRGO's prior presentation announcement was followed by a -3.74% 24-hour reaction, providing context for this scheduling notice. The platform record also shows moderate short positioning, a risk factor to monitor alongside the August event.

Key Figures

Conference edition: 46th Presentation date: August 12th Presentation time: 10:30 AM EDT +1 more

4 metrics

Conference edition 46th Canaccord Annual Growth Conference

Presentation date August 12th 2026 conference presentation

Presentation time 10:30 AM EDT August 12, 2026

Operating history over a century Perrigo company description

Historical Context

5 past events · Latest: Jul 22 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 22	Earnings date notice	Neutral	+0.0%	Second-quarter 2026 results scheduled for August 5 with an earnings conference call.
Jun 30	Board appointments	Positive	-0.8%	Two independent directors joined the board, followed by a negative 24-hour reaction.
Jun 08	Leadership transition	Negative	-3.7%	Interim CEO appointment followed the outgoing CEO's resignation and outlook reaffirmation.
May 26	Conference presentation	Neutral	-3.7%	Oppenheimer conference presentation announcement preceded a negative 24-hour price reaction.
May 06	Quarterly results	Negative	+5.3%	First-quarter sales decline and impairment charge preceded a positive 24-hour price reaction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent reactions were mixed, including a negative move after a prior presentation notice and a positive move after first-quarter results.

Key Terms

over-the-counter (otc)

1 terms

over-the-counter (otc) medical

"As a pioneer in the over-the-counter (OTC) self-care market"

Over-the-counter (OTC) describes stocks and other securities traded directly between buyers and sellers outside formal exchanges, using brokers, dealers, or electronic networks. For investors it matters because OTC trading often means lower transparency, fewer rules and thinner trading volume—like buying at a small flea market instead of a big supermarket—so prices can swing more and the risk of not being able to sell quickly is higher.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, July 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to present at the Canaccord 46th Annual Growth Conference, on Wednesday, August 12th at 10:30 AM EDT. 

The webcast can be accessed on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.

About Perrigo  

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill^®, Mederma^®, Compeed^®, EllaOne^®, and Jungle Formula^®.

For more information, visit www.perrigo.com.

Forward-Looking Statements 

This press release includes, and the matters discussed in Perrigo's presentation at the Canaccord 46th Annual Growth Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.

Perrigo Contacts

Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375, eric.jacobson@perrigo.com 

Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238, nicholas.gallagher@perrigo.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-302836962.html

SOURCE Perrigo Company plc

FAQ

When will Perrigo (NYSE: PRGO) present at the Canaccord 46th Annual Growth Conference?

Perrigo is scheduled to present on Wednesday, August 12 at 10:30 AM EDT. According to Perrigo, Interim President and CEO Albert Manzone and CFO Eduardo Bezerra will represent the company at the Canaccord 46th Annual Growth Conference.

How can investors access Perrigo’s webcast for the Canaccord 46th Annual Growth Conference?

Investors can access Perrigo’s webcast through the company’s investor relations website. According to Perrigo, the presentation will be available at http://perrigo.investorroom.com/events-webcasts at the scheduled time of the Canaccord 46th Annual Growth Conference.

Who from Perrigo (PRGO) will speak at the Canaccord 46th Annual Growth Conference?

Interim President and CEO Albert Manzone and CFO Eduardo Bezerra will speak for Perrigo. According to Perrigo, both executives are scheduled to present at the Canaccord 46th Annual Growth Conference on August 12 at 10:30 AM EDT.

What type of business does Perrigo (NYSE: PRGO) operate for investors following the conference?

Perrigo operates as a pure-play self-care company focused on over-the-counter health and wellness products. According to Perrigo, its cash-generative store brand private label segment helps fund investments in leading brands like Opill, Mederma, Compeed, EllaOne, and Jungle Formula.

In which regions does Perrigo (PRGO) primarily sell its self-care products?

Perrigo primarily serves consumers in North America and Europe with over-the-counter self-care products. According to Perrigo, the company has over a century of experience providing health and wellness solutions across multiple molecules, dosage forms, and value tiers.